QL-007 tablet
Sponsors
Qilu Pharmaceutical Co., Ltd.
Conditions
Chronic Hepatitis b
Phase 1
A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients
NCT03244085
Start: 2017-08-20End: 2018-12-30Target: 18Updated: 2018-07-16
A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA
NCT03770624
Start: 2018-10-16End: 2019-04-30Target: 60Updated: 2018-12-10